Estimating the efficacy of pharmacogenomics over a lifetime
It is well known that common variants in specific genes influence drug metabolism and response, but it is currently unknown what fraction of patients are given prescriptions over a lifetime that could be contraindicated by their pharmacogenomic profiles.To determine the clinical utility of pharmacogenomics over a lifetime in a general Appliance Pac